Prognostic predictive value of TLR4 polymorphisms in Han Chinese population with hypertrophic cardiomyopathy

Ke Han1, Yan-Ping Li2

  • 1Department of Cardiovascular Surgery, Yantai Affiliated Hospital of Binzhou Medical University, Shandong Province, China.

Insights

Toll-like receptor-4 (TLR4) gene variations are linked to hypertrophic cardiomyopathy (HCM) risk and prognosis in the Han Chinese population. Specific TLR4 polymorphisms correlate with increased susceptibility and poorer survival outcomes in HCM patients.

Area of Science:

  • Genetics
  • Cardiology
  • Immunology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary genetic heart condition and a significant cause of sudden cardiac death.
  • The role of genetic factors, specifically Toll-like receptor-4 (TLR4) gene polymorphisms, in HCM development and progression requires further investigation.

Purpose of the Study:

  • To investigate the association between Toll-like receptor-4 (TLR4) gene polymorphisms and hypertrophic cardiomyopathy (HCM) in a Han Chinese population.
  • To determine if specific TLR4 polymorphisms influence overall survival (OS) and prognosis in HCM patients.

Main Methods:

  • A case-control study involving 486 HCM patients and 214 healthy controls.
  • Genotyping of two TLR4 promoter single nucleotide polymorphisms (SNPs): -728G > C (rs11536865) and -2081G > A (rs10983755) using PCR-RFLP.
  • Analysis of SNP associations with HCM susceptibility, overall survival (Kaplan-Meier, Cox regression), and serum TLR4 levels (ELISA).

Main Results:

  • Allelic frequencies of C at -728G > C and A at -2081G > A were significantly higher in HCM patients compared to controls (P < 0.001).
  • Both TLR4 SNPs were associated with HCM susceptibility (P < 0.01) and overall survival (P < 0.001).
  • The CC genotype (-728G > C) and AA genotype (-2081G > A) were linked to poor HCM prognosis (P < 0.001). HCM patients exhibited elevated serum TLR4 levels (242.6 pg/ml vs. 135.7 pg/ml, P = 0.027).

Conclusions:

  • TLR4 gene polymorphisms, specifically -728G > C and -2081G > A, represent a genetic susceptibility factor for HCM in the Han Chinese population.
  • These polymorphisms are associated with increased risk, poorer prognosis, and elevated serum TLR4 levels in HCM patients.
  • TLR4 may play a significant role in the pathogenesis and clinical course of hypertrophic cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
490
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
568
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
538
Predicting Molecular Geometry02:27

Predicting Molecular Geometry

VSEPR Theory for Determination of Electron Pair Geometries
45.8K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Conservation of Small Populations02:04

Conservation of Small Populations

Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
17.3K